Startups

Care Continuity: Data-Driven Patient Navigation Company Closes $10 Million In Funding

By Annie Baker ● Jan 8, 2024

Care Continuity - a leader in data-driven patient navigation serving some of the country's largest health systems, payers, and ACOs - recently announced the closing of $10 million in Series A-3 funding co-led by Empactful Capital & Viewside Capital Partners with participation from Flat Creek Capital and Loop 289 Limited Partners.

Imbed Biosciences: $10 Million Raised In Round Led By Niterra

By Noah Long ● Jan 8, 2024

Niterra announced today its participation in the $10 million convertible debt financing for Imbed Biosciences (a tissue engineering company developing advanced biomaterials for soft-tissue repair). And Niterra’s investment was made through the CVC fund jointly operated with Pegasus Tech Ventures and this round included strong participation from existing investors.

Vortexa: $34 Million Secured To Accelerate Analytics Platform For Energy And Freight Markets

By Annie Baker ● Jan 8, 2024

Vortexa - the leading real-time global analytics platform for energy and freight markets - recently announced the successful completion of its $34 million Series C funding round. The investment funds managed by Morgan Stanley Expansion Capital spearheaded the funding, with strong participation from existing investors Notion Capital, Monashees, Metaplanet, FJ Labs, and Communitas Capital.

QuantHealth: Funding Raised From Accenture And Other Investors

By Dan Anderson ● Jan 8, 2024

QuantHealth - an AI-powered clinical trial design company that simulates clinical trials - recently announced it has received a strategic investment from Accenture Ventures, participation from a leading CRO firm, and additional investors. And the new funding brings the total Series A round to $17 million. It will enable QuantHealth to enhance its platform used by pharmaceutical and biotech companies to save millions on clinical trials and drug development.

Affinity Learning Raises Funding From O’Shaughnessy Ventures

By Amit Chowdhry ● Jan 8, 2024

O'Shaughnessy Ventures LLC - a family office that invests in ambitious seed and pre-seed startups - recently announced that it has invested in Affinity Learning.

Knownwell: AIaaS Platform Company Raises $2 Million In Pre-Seed Funding

By Annie Baker ● Jan 7, 2024

Knownwell - a pioneering AIaaS (Artificial Intelligence as a Service) platform company – recently announced the successful closing of a $2 million pre-seed round. This funding round marks a significant milestone in Knownwell's goal of transforming the professional services sector with its cutting-edge Intelligent Enterprise Operating System.

Clarametyx Biosciences: $33 Million Secured To Advance Anti-Biofilm Biologics For Bacterial Infections

By Annie Baker ● Jan 6, 2024

Clarametyx Biosciences - a clinical-stage company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms – recently announced the successful completion of a $33 million Series A round. The Series A financing was led by the Ohio Innovation Fund, with participation from current investors Nationwide Children’s Hospital, Rev1 Ventures, JobsOhio Growth Capital, C Bio Investors, and 1776 Fund.

Nabla: $24 Million Raised To Expand Ambient AI Assistant For Practitioners

By Amit Chowdhry ● Jan 6, 2024

Nabla – a leading ambient AI assistant for practitioners - recently announced the initial close of a $24 million Series B funding round led by Cathay Innovation, with participation from ZEBOX Ventures.

Banner Ridge: $2.15 Billion In Oversubscribed Secondary Fund V Closed

By Amit Chowdhry ● Jan 6, 2024

Banner Ridge Partners - a $7.3 billion multi-strategy private equity investment firm - has completed fundraising for Banner Ridge Secondary Fund V (BRP V) at its hard cap with $2.15 billion of total commitments. BRP V is the latest fund to be raised as part of the firm's flagship secondary program.

CRISPR QC: Genetic Medicine Company Closes $10 Million In Funding

By Dan Anderson ● Jan 6, 2024

CRISPR QC, a San Diego-based biotechnology company that has developed the world’s first platform to precisely analyze the quality of the CRISPR/CAS9 gene editing system – has raised $10 million in funding led by Xcellerant Ventures.

Credo Health: Medical Record Retrieval And Analysis Company Closes $5.25 Million In Funding

By Annie Baker ● Jan 6, 2024

Credo Health - a leader in technology for value-based care – recently announced it has successfully secured $5.25 million in series seed funding. FCA Venture Partners led the funding round with existing investors, including Hannah Grey VC, FirstMile Ventures, and SpringTime Ventures.

Nalu Medical: $65 Million Raised To Advance Treatments For Chronic Neuropathic Pain

By Noah Long ● Jan 5, 2024

Nalu Medical - a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain - recently announced the closing of a $65 million equity financing.

Heart + Paw Raises Significant Strategic Growth Investment From Whistler Capital

By Annie Baker ● Jan 5, 2024

Heart + Paw (H+P) - a veterinary and multi-service pet care company leading the future of pet care in digitally enabled and thoughtfully-designed locations - recently announced a significant strategic growth investment from Whistler Capital Partners, a leading healthcare-focused private equity firm. Heart + Paw will continue to be led by its existing management team, including founder and Chief Veterinary Officer Dr. George Melillo and CEO Dave Lasus. The financial terms were not disclosed.

TCG Crossover: Oversubscribed $1 Billion TCGX Fund II Closed

By Annie Baker ● Jan 5, 2024

TCG Crossover (TCGX) - a life sciences-focused investment firm with a fully flexible mandate to invest in both private and public companies - recently announced the closing of its second fund, TCGX Fund II, with $1 billion in capital, exceeding its original hard cap of $900 million in total capital commitments. This offering attracted strong support from new and existing limited partners, with commitments coming globally from investors in North America, Europe, the Middle East, and Asia.

Moonwalk Biosciences: Genomic Medicine Company Raises $57 Million

By Noah Long ● Jan 5, 2024

Moonwalk Biosciences - a genomic medicine company pioneering precision epigenetic medicines - recently announced the completion of $57 million in seed and Series A financing from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, GV, Khosla Ventures and YK Bioventures. The funding will support the continued advancement of Moonwalk’s epigenetic profiling and engineering technology platform and progress its pipeline of epigenetic therapeutics toward the clinic.

Reimagine Care: Strategic Investment From Oncology Ventures Raised

By Noah Long ● Jan 5, 2024

Reimagine Care - a leading provider of virtual-first cancer care - recently announced an investment from Oncology Ventures, a cancer-focused venture capital fund. This funding round marks a significant milestone in the combined pursuit of innovative and patient-centric approaches to cancer care delivery.

Happy Money Signs Strategic Deal With TruStage

By Annie Baker ● Jan 5, 2024

Happy Money - a leading platform for unsecured lending in partnership with credit unions - recently announced the close of a strategic transaction led by TruStage Ventures and other institutional investors. Happy Money remains a privately held company with independent operations under CEO Joe Heck.

Arbital Health: $10 Million Funding And Santa Barbara Actuaries Acquisition

By Dan Anderson ● Jan 5, 2024

Arbital Health - a technology startup focused on accelerating the healthcare industry's transition to value-based care - recently announced the acquisition of Santa Barbara Actuaries and $10 million in Series A financing led by digital healthcare investor Transformation Capital.

Chai: Social AI Platform Company Raises Funding At $450 Million Valuation

By Annie Baker ● Jan 5, 2024

AI platform Chai announced that CoreWeave (the leading specialized GPU cloud provider) will invest in the company, placing Chai at a $450 million valuation. This deal followed shortly after Chai's initial fundraising in June 2023, bringing the total capital invested in Chai to over $10 million.

Exponent Founders Capital Launched With $125 Million To Invest In Early-Stage Companies

By Amit Chowdhry ● Jan 5, 2024

Early stage venture capital firm Exponent Founders Capital launched and disclosed it has raised $125 million to date, including a new $75 million Fund II vehicle that will be deployed across promising inception and early stage companies spanning enterprise software, fintech and payments, infrastructure, applied AI, and vertical SaaS throughout the U.S., Canada, and Europe.

HI-Bio: $95 Million Raised To Develop Targeted Therapies For Immune-Mediated Diseases

By Amit Chowdhry ● Jan 5, 2024

Human Immunology Biosciences (HI-Bio) - a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs) - recently announced the closing of a $95 million Series B financing led by new investor Alpha Wave Global. Viking Global Investors and Arkin Bio Capital participated in the financing, and existing investors Jeito Capital and ARCH Venture Partners.

VMocion: $3 Million Raised To Improve Virtual Motion Technologies

By Annie Baker ● Jan 5, 2024

VMocion - an entertainment technology company based in Scottsdale, Arizona - recently announced a $3 million seed round for the advancement of its VMocion 3V and WAIV technologies.

UrbanStems: Modern Floral Gifting Company Secures $5 Million In Funding

By Annie Baker ● Jan 5, 2024

UrbanStems - a premier modern floral gifting company - recently announced that it has secured $5 million in Series C extension funding from existing investors. The funding fuels the company's growth strategy as it expands same-day delivery service to new cities across the U.S.

Vigilant Ops: SBMOM Automation Company Closes $2 Million In Funding

By Dan Anderson ● Jan 5, 2024

DataTribe - a global cyber foundry that invests in and co-builds next-generation cybersecurity and data science companies - recently announced a $2 million seed investment in Vigilant Ops, a leading automation platform for the generation, maintenance, and authenticated sharing of certified Software Bill of Materials (SBOM). Vigilant Ops (winner of the 6th annual DataTribe Challenge in November) performs continuous vulnerability monitoring and alerting, security patch notifications, and the ability to upload SBOMs - lists of the software libraries embedded in products - from alternate sources.

Perplexity: AI Search Company Raises $73.6 Million At A Reported $520 Million Valuation

By Amit Chowdhry ● Jan 5, 2024

Perplexity recently announced milestones reinforcing the company’s increasingly dominant role in this new era of AI-native search. Since publicly launching the world’s first fully functional conversational answer engine about a year ago, the company has grown to 10 million monthly active users and served over half a billion queries last year.

Ceretype Neuromedicine: Functional MRI Company Raises $2 Million

By Noah Long ● Jan 5, 2024

Ceretype Neuromedicine - a pioneer in the practical application and integration of functional MRI (fMRI) - recently announced that it has closed its second round of seed financing. And the company’s $2 million funding target was oversubscribed.

Vasa Therapeutics Raises $6 Million In Seed Funding To Develop Therapies For Cardiovascular Aging Diseases

By Dan Anderson ● Jan 4, 2024

Vasa Therapeutics - a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging - recently announced the closing of $6 million in series seed funding led by Orphinic Scientific SA. The funding round also included participation from private investment funds NuFund Venture Group, SeedFolio, and others.

Radionetics Oncology: $52.5 Million Secured To Advance Radiopharmaceutical Pipeline

By Annie Baker ● Jan 4, 2024

Radionetics Oncology - a clinical-stage radiopharmaceutical company focused on discovering and developing novel agents for treating a wide range of oncology indications - recently announced the completion of a $52.5 million Series A financing. The funding round was led by Frazier Life Sciences, 5AM Ventures, and new investor, DCVC Bio, with participation from Crinetics Pharmaceuticals and GordonMD Global Investments, raising the total to $82.5 million.

Aqua Security: $60 Million Funding Raised At Over $1 Billion Valuation

By Amit Chowdhry ● Jan 4, 2024

Aqua Security - a pioneer in cloud-native security - recently announced it had secured $60 million in funding, led by new investor Evolution Equity Partners, with participation from existing investors Insight Partners, Lightspeed Venture Partners, and StepStone Group. The funding - which is an extension of the company’s Series E round - placed Aqua’s valuation above $1 billion.

Vita Inclinata: $44 Million Closed To Create A Safety Ecosystem For Rescue Crews

By Noah Long ● Jan 4, 2024

Vita Inclinata Technologies - an innovator in intelligent lifting hardware and software for rescue crews and other field safety applications - recently announced that it secured $44 million in funding from 3&1 Fund, a global leader in IP (Intellectual Property) based financing solutions. Utilizing a debt structure, 3&1 Fund offered a compelling alternative to traditional equity-based venture capital financing, which will boost Vita Inclinata Technologies' expansion initiatives.